225 related articles for article (PubMed ID: 29221425)
1. Riluzole does not improve lifespan or motor function in three ALS mouse models.
Hogg MC; Halang L; Woods I; Coughlan KS; Prehn JHM
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):438-445. PubMed ID: 29221425
[TBL] [Abstract][Full Text] [Related]
2. Riluzole Exhibits No Therapeutic Efficacy on a Transgenic Rat model of Amyotrophic Lateral Sclerosis.
Chen S; Liao Q; Lu K; Zhou J; Huang C; Bi F
Curr Neurovasc Res; 2020; 17(3):275-285. PubMed ID: 32271694
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Zhao Z; Fu J; Li S; Li Z
J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663
[TBL] [Abstract][Full Text] [Related]
4. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis.
Gifondorwa DJ; Robinson MB; Hayes CD; Taylor AR; Prevette DM; Oppenheim RW; Caress J; Milligan CE
J Neurosci; 2007 Nov; 27(48):13173-80. PubMed ID: 18045911
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
6. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model.
Waibel S; Reuter A; Malessa S; Blaugrund E; Ludolph AC
J Neurol; 2004 Sep; 251(9):1080-4. PubMed ID: 15372249
[TBL] [Abstract][Full Text] [Related]
7. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis.
Gurney ME; Fleck TJ; Himes CS; Hall ED
Neurology; 1998 Jan; 50(1):62-6. PubMed ID: 9443458
[TBL] [Abstract][Full Text] [Related]
8. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
10. A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosis.
Sher RB; Heiman-Patterson TD; Blankenhorn EA; Jiang J; Alexander G; Deitch JS; Cox GA
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):588-600. PubMed ID: 25008789
[TBL] [Abstract][Full Text] [Related]
11. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic biomarkers for assessing disease progression and the effect of riluzole in SOD1 G93A ALS mice.
Li J; Sung M; Rutkove SB
PLoS One; 2013; 8(6):e65976. PubMed ID: 23762454
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of ALS.
Münch C; Ludolph AC
Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
[TBL] [Abstract][Full Text] [Related]
15. Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis.
Wright AL; Della Gatta PA; Le S; Berning BA; Mehta P; Jacobs KR; Gul H; San Gil R; Hedl TJ; Riddell WR; Watson O; Keating SS; Venturato J; Chung RS; Atkin JD; Lee A; Shi B; Blizzard CA; Morsch M; Walker AK
Eur J Neurosci; 2021 Sep; 54(6):6237-6255. PubMed ID: 34390052
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of Withania somnifera extract in SOD1
Dutta K; Patel P; Julien JP
Exp Neurol; 2018 Nov; 309():193-204. PubMed ID: 30134145
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
18. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
19. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
[TBL] [Abstract][Full Text] [Related]
20. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
